Atorable Gold 40 Tablet contains Aspirin 75mg + Atorvastatin 40mg + Clopidogrel 75mg, a potent triple combination designed for comprehensive cardiovascular protection. Atorvastatin lowers cholesterol, Aspirin provides antiplatelet action, and Clopidogrel prevents thrombotic events, making it ideal for patients at high risk of heart attacks or strokes.
This triple therapy simplifies treatment, reducing pill burden while maintaining effective lipid control and blood thinning, enhancing compliance and clinical outcomes in patients with cardiovascular disease, coronary artery disease, or prior ischemic events.
For distributors and resellers, Atorable Gold 40 Tablet is a high-demand cardiology product, frequently prescribed in cardiology OPDs, preventive care clinics, and hospital cardiovascular units. Its constant clinical necessity ensures steady demand and repeated orders throughout the year.
Adding Atorable Gold 40 Tablet to your cardiology and triple therapy portfolio strengthens your product catalogue, opening strong opportunities in hospital supply, pharmacy distribution, institutional tenders, export channels, and third-party manufacturing. Its high clinical relevance makes it a profitable and strategic addition for pharmaceutical distributors.